METTL14 is central to various common cancers, including hepatocellular carcinoma (HCC) [11], breast cancer (BC) [12], prostate cancer [13], glioma [14], and leukemia [15], nonsmall cell lung cancer (NSCLC) [16]. Here, METTL14 is linked to hepatocellular carcinoma.